AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens

Acute myeloid leukemia (AML) is a disease that mainly affects elderly patients who are more often unfit for intensive chemotherapy (median age of diagnosis is 68). The regimens, including venetoclax, a highly specific BCL-2 (B-cell lymphoma-2) inhibitor, are a common alternative because of their saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Milnerowicz, Szymon, Maszewska, Julia, Skowera, Paulina, Stelmach, Magdalena, Lejman, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647248/
https://www.ncbi.nlm.nih.gov/pubmed/37958832
http://dx.doi.org/10.3390/ijms242115849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647248/
https://www.ncbi.nlm.nih.gov/pubmed/37958832
http://dx.doi.org/10.3390/ijms242115849

Ejemplares similares